Delivery Order SPE2DB24D6044-SPE2DB25FLJEX
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.55 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of XYLOCAINE 2%-EPI 1:200,000 20ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,218.78 and a performance period through March 20, 2024. This delivery order was issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $1,776.00, is for the supply of 50 milliliter bottles of Xylocaine 1% with Epinephrine 1:100,000 medication. The delivery order has a performance period ending on March 29, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,139.82 firm-fixed-price delivery order is for the supply of XYLOCAINE 2%-EPI 1:200,000 20ML, a local anesthetic medication. The contract has an ultimate completion date of March 14, 2024 and was awarded on March 13, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYLOCAINE 1%-EPI 1:100,000 50ML, a pharmaceutical product. The contract has a ceiling value of $2,288.37 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of Xylocaine 1%-EPI 1:100,000 50ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $2,775.00 and an ultimate completion date of July 31, 2024. The award was made on July 30, 2024 and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $178,980 firm fixed price delivery order to Amerisourcebergen Drug Corporation for XYLOCAINE 1%-EPI 1:100,000 20ML. The prime contractor will deliver the requested pharmaceutical products from its Conshohocken, Pennsylvania facility to support DLA programs. No major subcontractors or set aside designations were indicated. DLA manages the global supply chain for the military services and other federal agencies, procuring a wide range of medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.13 firm fixed-price delivery order is for the supply of 4566747173 ! XYLOCAINE 1%-EPI 1:100,000 50ML, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.52 firm-fixed-price delivery order is for XYLOCAINE 2%-EPI 1:200,000 10ML, a specialty medication. The contract has an ultimate completion date of November 21, 2024 and was awarded on November 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This federal contract award, valued at $1,462.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xylocaine 1%-Epi 1:100,000 50ml, a local anesthetic medication. The contract, which has a completion date of December 4, 2023, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJEXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xylocaine 2%-Epinephrine 1:200,000 in 20mL vials, with a ceiling value of $1,477.46. The contract was awarded on July 21, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 22, 2025. No set-aside designation was applied, indicating this was a competitively awarded contract. The point of performance is AmerisourceBergen Drug Corp's facility in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor contract extending through December 2026. This IDC serves as a comprehensive vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contract portfolio and consistent performance on competitively awarded delivery orders demonstrate its established capability as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/21/25 |